Civic Intelligence

Bioadvance DBA the Biotechnology Greenhouse of Southeastern Pennsylvania

990 • Fiscal year 2020 • EIN 46-0481876

Jul 01, 2019 to Jun 30, 2020 • Filed on May 11, 2021

Organization ProfileWWW.BIOADVANCE.COM

View Organization Page

170 N Radnor-chester Road No 350Radnor, PA 19087

(610) 230-0536

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

9th percentile

0.01x

Higher debt load relative to assets than 9% of similar nonprofits.

2020 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2020

Liabilities / Revenue

10th percentile

0.05x

Higher debt load relative to revenue than 10% of similar nonprofits.

2020 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2020

Net Margin

97th percentile

82%

Higher net margin than 97% of similar nonprofits.

2020 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2020

Top Officer Pay

52nd percentile

$354,026

Higher top officer pay than 52% of similar nonprofits.

Top officer pay equals 2.7% of source-year revenue.

2020 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2020

Asset Growth

76th percentile

19%

Faster asset growth than 76% of similar nonprofits.

2020 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2019 to 2020

Revenue Growth

98th percentile

406%

Faster revenue growth than 98% of similar nonprofits.

2020 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets9th percentile

Assets

Up

$78,551,910

Up $12,506,438 (+19%) from 2019

Net Assets

Up

$77,901,389

Up $12,467,115 (+19%) from 2019

Liabilities

Up

$650,521

Up $39,323 (+6.4%) from 2019

Revenue And Expenses
Liabilities / Revenue10th percentileNet Margin97th percentile

Revenue

Up

$12,959,074

Up $10,400,168 (+406%) from 2019

Expenses

Down

$2,328,525

Down $98,666 (-4.1%) from 2019

Net Income

Up

$10,630,549

Up $10,498,834 (+7971%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth76th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $27,741,940Liabilities 2010: $477,969Net Assets 2010: $27,263,9712010Assets 2011: $27,011,673Liabilities 2011: $364,805Net Assets 2011: $26,646,8682011Assets 2012: $25,630,285Liabilities 2012: $540,305Net Assets 2012: $25,089,9802012Assets 2013: $26,647,958Liabilities 2013: $322,982Net Assets 2013: $26,324,9762013Assets 2014: $31,553,912Liabilities 2014: $465,297Net Assets 2014: $31,088,6152014Assets 2015: $28,978,459Liabilities 2015: $276,446Net Assets 2015: $28,702,0132015Assets 2016: $61,373,001Liabilities 2016: $614,234Net Assets 2016: $60,758,7672016Assets 2017: $60,962,570Liabilities 2017: $608,169Net Assets 2017: $60,354,4012017Assets 2018: $60,326,743Liabilities 2018: $637,973Net Assets 2018: $59,688,7702018Assets 2019: $66,045,472Liabilities 2019: $611,198Net Assets 2019: $65,434,2742019Assets 2020: $78,551,910Liabilities 2020: $650,521Net Assets 2020: $77,901,3892020Assets 2021: $80,190,811Liabilities 2021: $424,660Net Assets 2021: $79,766,1512021Assets 2022: $73,104,917Liabilities 2022: $301,566Net Assets 2022: $72,803,3512022Assets 2023: $81,948,557Liabilities 2023: $4,605,680Net Assets 2023: $77,342,8772023

Highlighted filing

2020

Assets$78,551,910
Liabilities$650,521
Net Assets$77,901,389
Open 2020 Filing

Operations Trend

Revenue Growth98th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MExpenses 2010: $2,263,8742010Revenue 2011: $1,054,718Expenses 2011: $2,129,907Net Income 2011: -$1,075,1892011Expenses 2012: $2,039,6442012Expenses 2013: $2,040,1512013Revenue 2014: $5,921,552Expenses 2014: $1,989,408Net Income 2014: $3,932,1442014Revenue 2015: $1,845,392Expenses 2015: $1,954,957Net Income 2015: -$109,5652015Revenue 2016: $36,568,950Expenses 2016: $1,997,694Net Income 2016: $34,571,2562016Revenue 2017: $2,547,864Expenses 2017: $2,048,992Net Income 2017: $498,8722017Revenue 2018: $2,635,201Expenses 2018: $2,254,734Net Income 2018: $380,4672018Revenue 2019: $2,558,906Expenses 2019: $2,427,191Net Income 2019: $131,7152019Revenue 2020: $12,959,074Expenses 2020: $2,328,525Net Income 2020: $10,630,5492020Revenue 2021: $2,931,752Expenses 2021: $2,412,456Net Income 2021: $519,2962021Revenue 2022: $2,523,586Expenses 2022: $2,278,521Net Income 2022: $245,0652022Revenue 2023: $1,586,292Expenses 2023: $2,508,519Net Income 2023: -$922,2272023

Highlighted filing

2020

Revenue$12,959,074
Expenses$2,328,525
Net Income$10,630,549
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2019 to Jun 30, 2020
Signed
May 11, 2021
Return Version
2019v5.2
Gross Receipts
$40,222,412
Mission and Program Overview

Mission

The biotechnology greenhouse of southeastern pennsylvania was established with funds from the commonwealth of pennsylvania's share of the national tobacco settlement to accelerate growth of the life sciences industry by transforming the southeast pennsylvania region's strength in biomedical research and development into commercial opportunities. Approximately $25 million of the original government grant funding has been dedicated for pre-seed or "gap" funding for promising therapeutic, biomedical device and related technology companies, in a program called the greenhouse fund. The greenhouse fund is designed to move promising scientific projects out of the laboratory and into commercial opportunities. Additional funds were set aside for initiatives to increase the region's strengths in biomedical informatics and clinical trials.

Bioadvance was established in 2001 as one of three life sciences greenhouses funded with a share of pennsylvania's national tobacco settlement revenues, to promote human health by supporting biomedical innovation in the southeastern pa region. Bioadvance dedicated $25 million of the original grant funding for pre-seed and early-stage funding to help move technologies to the next stage of development and to support the initiatives intended to increase the region's strength in biomedical informatics and clinical trials. Since the original grant funding was expended, bioadvance continues to support emerging life sciences companies in southeastern pa and the surrounding mid-atlantic region that are focused on technologies to improve human health. As of june 30, 2020, a total of $49.1 million has been invested by bioadvance in 93 companies and academic technologies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$18,850,856$27,730,247▲ $8,879,391
Investments Program Related$22,687,232$27,666,600▲ $4,979,368
Investments in Publicly Traded Securities$24,209,887$22,355,989▼ $1,853,898
Pledges and Grants Receivable-$500,000-
Prepaid Expenses and Deferred Charges$225,177$171,190▼ $53,987
Cash and Non-Interest-Bearing Accounts$51,051$114,254▲ $63,203
Land, Buildings, and Equipment, Net$21,269$13,630▼ $7,639
Total Assets$66,045,472$78,551,910▲ $12,506,438
Liabilities
Accounts Payable and Accrued Expenses$369,532$650,521▲ $280,989
Deferred Revenue$241,666--
Total Liabilities$611,198$650,521▲ $39,323
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$65,434,274$77,901,389▲ $12,467,115
Total Net Assets Fund Balance$65,434,274$77,901,389▲ $12,467,115
Total Liabilities and Net Assets / Fund Balance$66,045,472$78,551,910▲ $12,506,438

Asset Categories

AssetBook ValueDepreciationBasis
Leasehold Improvements$0$165,927$165,927
Equipment$13,630$85,919$99,549
Investment Program Related Org$3,493,003--
Compensation and Service Providers
Top Officer Pay52nd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Frederick JonesVP and SecretaryFT$265,309$88,717$354,026
Barbara S SchilbergCEO & Managing DirectorFT$280,100$66,718$346,818
Shahram HejaziVP and TreasurerPT$263,066$76,577$339,643
Robert DriscollDirector of FinanceFT$179,552$55,865$235,417
Marnie MccoyProgram DirectorFT$124,113$12,807$136,920

Board Members and Trustees

NameTitle
J Larry Jameson Md PhdDirector
John Daly MdDirector
John GillDirector
Lauren LenfestDirector
Philip Gerbino PharmdDirector
Russel Kaufman MdDirector
STEPHEN D'ETTORREDirector
Steven Nichtberger MdDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$1,241,666
Program Service Revenue
$9,357,335
Investment Income
$947,651
Other Revenue
$1,412,422
Change in Net Assets
$10,630,549

Audited Revenue Reconciliation

Revenue per Audited Statements
$3,478,756
Revenue Not Reported on Financial Statements
$9,480,318
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$9,480,318
Total Revenue per Audited Statements
$3,478,756
Total Revenue per Form 990
$12,959,074
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,562,664
Other Expenses$765,861
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$946,645$104,434-$1,051,079
Other Salaries and Wages$111,923$283,921-$395,844
Fees for Services Other$219,416$20,529-$239,945
Occupancy-$207,004-$207,004
Insurance-$63,012-$63,012
Payroll Taxes$43,167$17,336-$60,503
Fees for Services Accounting-$46,500-$46,500
Other Employee Benefits$10,970$34,506-$45,476
Information Technology-$28,553-$28,553
Fees for Services Lobbying-$24,130-$24,130
Office Expenses-$17,829-$17,829
All Other Expenses$300$11,559-$11,859
Depreciation Depletion-$10,737-$10,737
Other Expenses$47,532$10,700-$10,700
Pension Plan Contributions$2,201$7,561-$9,762
Conferences and Meetings-$7,354-$7,354
Fees for Services Legal$2,741--$2,741
Travel$88$2,587-$2,675
Fees for Service Investment Mgmnt Fees-$126-$126
Total Functional Expenses$1,384,983$943,542$0$2,328,525

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,328,525
Total Expenses per Audited Statements$2,328,525
Total Expenses per Form 990$2,328,525
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Before the form 990 is filed with the irs, the form is distributed to the organization's board of directors for their review and comments.”

Form 990, Part VI, Section B, Line 12C

“Annually, the organization has its employees and board of directors sign a conflict of interest statement.”

Form 990, Part VI, Section B, Line 15

“Bioadvance recommended to the organization's compensation committee of the board of directors the salary increase for its ceo and officers for the year. After review and discussion, the compensation committee of the board of directors determined the appropriate salary increases.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are available upon request.”

Filing and Contact Details

Filer

Filer Name
Bioadvance Dba the Biotechnology
EIN
46-0481876
Phone
6102300536
Address
170 N RADNOR-CHESTER ROAD NO 350, RADNOR, PA 19087
Doing Business As
The Biotechnology Greenhouse of Southeastern Pennsylvania

Signing Officer

Name
Barbara S Schilberg
Title
Managing Director & CEO
Phone
6102300536
Signed
2021-05-11
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Barbara S Schilberg
Formed
2002
Legal Domicile
Pa
Voting Board Members
9
Independent Board Members
8
Employees
5
Volunteers
0

Preparer

Firm
Eisneramper Llp
Address
130 NORTH 18TH STREET SUITE 3000, PHILADELPHIA, PA 19103-2757
Preparer
Helen M Martin
Phone
2158818800
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Consulting: program service expenses 219,416. Management and general expenses 20,529. Fundraising expenses 0. Total expenses 239,945.”

FORM 990, PART XI, LINE 9:

“Unrealized gain on portfolio investments 1,889,838.”

Financial Statement Notes

PART X, LINE 2:

“The internal revenue service has classified bioadvance as exempt from federal income taxes under section 501(c)(3) of the internal revenue code. U.s. Gaap requires management to evaluate tax positions taken and recognize a tax liability, if bioadvance has taken an uncertain tax position that more likely than not would not be sustained upon examination by a government authority. Management has analyzed the tax positions taken by bioadvance and has concluded that as of june 30, 2020 and 2019, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or disclosure in the consolidated financial statements. Bioadvance recognizes interest and penalties associated with income taxes, if any, as part of interest and administrative expenses. There were no income tax related interest and penalties recorded for either of the years ended june 30, 2020 or 2019.”

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Realized gain on cash investments 122,983. Realized gain on portfolio investments 9,357,335.”

Raw XML AppendixShowing 400 of 616 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0369532
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0650521
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION. BIOADVANCE DEDICATED $25 MILLION OF THE ORIGINAL GRANT FUNDING FOR PRE-SEED AND EARLY-STAGE FUNDING TO HELP MOVE TECHNOLOGIES TO THE NEXT STAGE OF DEVELOPMENT AND TO SUPPORT THE INITIATIVES INTENDED TO INCREASE THE REGION'S STRENGTH IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS. SINCE THE ORIGINAL GRANT FUNDING WAS EXPENDED, BIOADVANCE CONTINUES TO SUPPORT EMERGING LIFE SCIENCES COMPANIES IN SOUTHEASTERN PA AND THE SURROUNDING MID-ATLANTIC REGION THAT ARE FOCUSED ON TECHNOLOGIES TO IMPROVE HUMAN HEALTH. AS OF JUNE 30, 2020, A TOTAL OF $49.1 MILLION HAS BEEN INVESTED BY BIOADVANCE IN 93 COMPANIES AND ACADEMIC TECHNOLOGIES.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt011559
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0300
IRS990/AllOtherExpensesGrp/TotalAmt011859
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ROBERT DRISCOLL DIRECTOR OF FINANCE
IRS990/BooksInCareOfDetail/PhoneNum06102300536
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0170 N RADNOR-CHESTER ROAD SUITE 350
IRS990/BooksInCareOfDetail/USAddress/CityNm0RADNOR
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019087
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt051051
IRS990/CashNonInterestBearingGrp/EOYAmt0114254
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0104434
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0946645
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt01051079
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt07354
IRS990/ConferencesMeetingsGrp/TotalAmt07354
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01241666
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt0947651
IRS990/CYOtherExpensesAmt0765861
IRS990/CYOtherRevenueAmt01412422
IRS990/CYProgramServiceRevenueAmt09357335
IRS990/CYRevenuesLessExpensesAmt010630549
IRS990/CYSalariesCompEmpBnftPaidAmt01562664
IRS990/CYTotalExpensesAmt02328525
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt012959074
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0241666
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt010737
IRS990/DepreciationDepletionGrp/TotalAmt010737
IRS990/Desc0GREENHOUSE PROGRAM - THE CORNERSTONE OF BIOADVANCE INVESTMENT ACTIVITIES - WAS LAUNCHED TWO MONTHS AFTER RECEIVING THE DCED GRANT. THE PROGRAM FUNDS YOUNG COMPANIES FOR RESEARCH, DEVELOPMENT AND COMMERCIALIZATION ACTIVITIES THAT WILL PROVIDE ENOUGH PROGRESS TO ENABLE THEM TO ATTRACT VENTURE CAPITAL OR AN INDUSTRY PARTNER. INDIVIDUAL COMPANIES ARE ELIGIBLE TO RECEIVE UP TO $1,500,000 WHICH OFTEN IS DISBURSED AS MILESTONES ARE ACHIEVED, UNLESS THE CAP IS INCREASED BY THE BOARD. THE INVESTMENTS ARE IN THE FORM OF EQUITY OR A NOTE THAT CONVERTS INTO EQUITY UPON A SPECIFIED MINIMUM SIZE OF DOLLAR FUNDING.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DoingBusinessAsName/BusinessNameLine1Txt0THE BIOTECHNOLOGY GREENHOUSE OF SOUTHEASTERN PENNSYLVANIA
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt05
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01384983
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt046500
IRS990/FeesForServicesAccountingGrp/TotalAmt046500
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt02741
IRS990/FeesForServicesLegalGrp/TotalAmt02741
IRS990/FeesForServicesLobbyingGrp/ManagementAndGeneralAmt024130
IRS990/FeesForServicesLobbyingGrp/TotalAmt024130
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt020529
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0219416
IRS990/FeesForServicesOtherGrp/TotalAmt0239945
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt0126
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0126
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt232.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt120.50
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt055592
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt126718
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt243732
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt338265
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt412807
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/PersonNm0FREDERICK JONES
IRS990/Form990PartVIISectionAGrp/PersonNm1BARBARA S SCHILBERG
IRS990/Form990PartVIISectionAGrp/PersonNm2SHAHRAM HEJAZI
IRS990/Form990PartVIISectionAGrp/PersonNm3ROBERT DRISCOLL
IRS990/Form990PartVIISectionAGrp/PersonNm4MARNIE MCCOY
IRS990/Form990PartVIISectionAGrp/PersonNm5JOHN DALY MD
IRS990/Form990PartVIISectionAGrp/PersonNm6STEPHEN D'ETTORRE
IRS990/Form990PartVIISectionAGrp/PersonNm7PHILIP GERBINO PHARMD
IRS990/Form990PartVIISectionAGrp/PersonNm8JOHN GILL
IRS990/Form990PartVIISectionAGrp/PersonNm9J LARRY JAMESON MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm10RUSSEL KAUFMAN MD
IRS990/Form990PartVIISectionAGrp/PersonNm11LAUREN LENFEST
IRS990/Form990PartVIISectionAGrp/PersonNm12STEVEN NICHTBERGER MD
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0298434
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1320100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt2295911
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3197152
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4124113
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/TitleTxt0VP AND SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt1CEO & MANAGING DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2VP AND TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR OF FINANCE
IRS990/Form990PartVIISectionAGrp/TitleTxt4PROGRAM DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0122983
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt09
IRS990/GovernmentGrantsAmt01241666
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt027386321
IRS990/GrossReceiptsAmt040222412
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt08
IRS990/IndivRcvdGreaterThan100KCnt05
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt028553
IRS990/InformationTechnologyGrp/TotalAmt028553
IRS990/InsuranceGrp/ManagementAndGeneralAmt063012
IRS990/InsuranceGrp/TotalAmt063012
IRS990/InvestmentIncomeGrp/ExclusionAmt0802246
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt022422
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0824668
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt022687232
IRS990/InvestmentsProgramRelatedGrp/EOYAmt027666600
IRS990/InvestmentsPubTradedSecGrp/BOYAmt024209887
IRS990/InvestmentsPubTradedSecGrp/EOYAmt022355989
IRS990/IRPDocumentCnt025
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0251846
IRS990/LandBldgEquipBasisNetGrp/BOYAmt021269
IRS990/LandBldgEquipBasisNetGrp/EOYAmt013630
IRS990/LandBldgEquipCostOrOtherBssAmt0265476
IRS990/LegalDomicileStateCd0PA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt027263338
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION. BIOADVANCE DEDICATED $25 MILLION OF THE ORIGINAL GRANT FUNDING FOR PRE-SEED AND EARLY-STAGE FUNDING TO HELP MOVE TECHNOLOGIES TO THE NEXT STAGE OF DEVELOPMENT AND TO SUPPORT THE INITIATIVES INTENDED TO INCREASE THE REGION'S STRENGTH IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS. SINCE THE ORIGINAL GRANT FUNDING WAS EXPENDED, BIOADVANCE CONTINUES TO SUPPORT EMERGING LIFE SCIENCES COMPANIES IN SOUTHEASTERN PA AND THE SURROUNDING MID-ATLANTIC REGION THAT ARE FOCUSED ON TECHNOLOGIES TO IMPROVE HUMAN HEALTH. AS OF JUNE 30, 2020, A TOTAL OF $49.1 MILLION HAS BEEN INVESTED BY BIOADVANCE IN 93 COMPANIES AND ACADEMIC TECHNOLOGIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt065434274
IRS990/NetAssetsOrFundBalancesEOYAmt077901389
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0122983
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0122983
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-53272
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt065434274
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt077901389
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0207004
IRS990/OccupancyGrp/TotalAmt0207004
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt017829
IRS990/OfficeExpensesGrp/TotalAmt017829
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt01889838
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt034506
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt010970
IRS990/OtherEmployeeBenefitsGrp/TotalAmt045476
IRS990/OtherExpensesGrp/Desc0DATABASE
IRS990/OtherExpensesGrp/Desc1PUBLIC RELATIONS
IRS990/OtherExpensesGrp/Desc2MEMBERSHIPS
IRS990/OtherExpensesGrp/Desc3SPONSORSHIPS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt027564
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt117600
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt210700
IRS990/OtherExpensesGrp/ProgramServicesAmt047532
IRS990/OtherExpensesGrp/TotalAmt047532
IRS990/OtherExpensesGrp/TotalAmt127564
IRS990/OtherExpensesGrp/TotalAmt217600
IRS990/OtherExpensesGrp/TotalAmt310700
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0283921
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0111923
IRS990/OtherSalariesAndWagesGrp/TotalAmt0395844
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt017336
IRS990/PayrollTaxesGrp/ProgramServicesAmt043167
IRS990/PayrollTaxesGrp/TotalAmt060503
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt07561
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt02201
IRS990/PensionPlanContributionsGrp/TotalAmt09762
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0500000
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0225177
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0171190
IRS990/PrincipalOfficerNm0BARBARA S SCHILBERG
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0525990
IRS990/ProgramServiceRevenueGrp/Desc0NET GAIN ON PROGRAM-RELATED INVES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt09357335
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt09357335
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01000000
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt01475144
IRS990/PYOtherExpensesAmt0888780
IRS990/PYOtherRevenueAmt0148475
IRS990/PYProgramServiceRevenueAmt0-64713
IRS990/PYRevenuesLessExpensesAmt0131715
IRS990/PYSalariesCompEmpBnftPaidAmt01538411
IRS990/PYTotalExpensesAmt02427191
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02558906
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt010630549
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd01
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt010792179
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt01412422
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt01412422
IRS990/SavingsAndTempCashInvstGrp/BOYAmt018850856
IRS990/SavingsAndTempCashInvstGrp/EOYAmt027730247
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01241666
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01000000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01483332
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01479166
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01457484
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt06661648
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt02237090
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt01608758
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt01119889
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0616847
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt02248164
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt07830748
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt033393324
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.45970
IRS990ScheduleA/PublicSupportPY170Pct00.52840
IRS990ScheduleA/PublicSupportTotal170Amt06661648
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01241666
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01000000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01483332
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01479166
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01457484
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt06661648
IRS990ScheduleA/TotalSupportAmt014492396
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/DirectContactLegislatorsAmt020000
IRS990ScheduleC/DirectContactLegislatorsInd01
IRS990ScheduleC/GrantsOtherOrganizationsInd00
IRS990ScheduleC/MailingsMembersInd00
IRS990ScheduleC/MediaAdvertisementsInd00
IRS990ScheduleC/NotDescribedSection501c3Ind00
IRS990ScheduleC/OtherActivitiesInd00
IRS990ScheduleC/PaidStaffOrManagementInd00
IRS990ScheduleC/PublicationsOrBroadcastInd00
IRS990ScheduleC/RalliesDemonstrationsInd00
IRS990ScheduleC/SupplementalInformationDetail/ExplanationTxt0BIOADVANCE PAID GREENLEE PARTNERS LLC FOR ITS SHARE OF FEES TO MEET WITH STATE LEGISLATORS TO ADVOCATE ON BEHALF OF BIOADVANCE AND TWO OTHER LIFE SCIENCE GREENHOUSES.
IRS990ScheduleC/SupplementalInformationDetail/FormAndLineReferenceDesc0PART II-B, LINE 1:
IRS990ScheduleC/TotalLobbyingExpendituresAmt020000
IRS990ScheduleC/VolunteersInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt013630
IRS990ScheduleD/EquipmentGrp/DepreciationAmt085919
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt099549
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02328525
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt024148597
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt125000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt23493003
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc0COMMON & PREFERRED INVESTMENTS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc1INVESTMENT IN PLSG ACCELERATOR
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc2NOTES RECEIVABLE
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd0F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd1F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd2F
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt00
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0165927
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt0165927
IRS990ScheduleD/OtherRevenuesNotIncludedAmt09480318
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt09480318
IRS990ScheduleD/RevenueSubtotalAmt03478756
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE INTERNAL REVENUE SERVICE HAS CLASSIFIED BIOADVANCE AS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. U.S. GAAP REQUIRES MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN AND RECOGNIZE A TAX LIABILITY, IF BIOADVANCE HAS TAKEN AN UNCERTAIN TAX POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY A GOVERNMENT AUTHORITY. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY BIOADVANCE AND HAS CONCLUDED THAT AS OF JUNE 30, 2020 AND 2019, THERE ARE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. BIOADVANCE RECOGNIZES INTEREST AND PENALTIES ASSOCIATED WITH INCOME TAXES, IF ANY, AS PART OF INTEREST AND ADMINISTRATIVE EXPENSES. THERE WERE NO INCOME TAX RELATED INTEREST AND PENALTIES RECORDED FOR EITHER OF THE YEARS ENDED JUNE 30, 2020 OR 2019.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1REALIZED GAIN ON CASH INVESTMENTS 122,983. REALIZED GAIN ON PORTFOLIO INVESTMENTS 9,357,335.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART X, LINE 2:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1PART XI, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt013630
IRS990ScheduleD/TotalBookValueProgramRltdAmt027666600
IRS990ScheduleD/TotalExpensesPerForm990Amt02328525
IRS990ScheduleD/TotalRevenuePerForm990Amt012959074
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt03478756
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt02328525
IRS990ScheduleJ/AnyNonFixedPaymentsInd00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$78,551,910
Liabilities
$650,521
Net assets
$77,901,389
Revenue
$12,959,074
Expenses
$2,328,525
Net income
$10,630,549
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Summary only. Only limited summary data is available for this year.$81.9$4.61$77.3$1.59$2.51$0.92
2022Summary only. Only limited summary data is available for this year.$73.1$0.30$72.8$2.52$2.28$0.25
2021Summary only. Only limited summary data is available for this year.$80.2$0.42$79.8$2.93$2.41$0.52
2020Detailed filing. Detailed filing data is available for this year.$78.6$0.65$77.9$13.0$2.33$10.6
2019Summary only. Only limited summary data is available for this year.$66.0$0.61$65.4$2.56$2.43$0.13
2018Summary only. Only limited summary data is available for this year.$60.3$0.64$59.7$2.64$2.25$0.38
2017Summary only. Only limited summary data is available for this year.$61.0$0.61$60.4$2.55$2.05$0.50
2016Summary only. Only limited summary data is available for this year.$61.4$0.61$60.8$36.6$2.00$34.6
2015Summary only. Only limited summary data is available for this year.$29.0$0.28$28.7$1.85$1.95$0.11
2014Summary only. Only limited summary data is available for this year.$31.6$0.47$31.1$5.92$1.99$3.93
2013Summary only. Only limited summary data is available for this year.$26.6$0.32$26.3$2.04
2012Summary only. Only limited summary data is available for this year.$25.6$0.54$25.1$2.04
2011Summary only. Only limited summary data is available for this year.$27.0$0.36$26.6$1.05$2.13$1.08
2010Summary only. Only limited summary data is available for this year.$27.7$0.48$27.3$2.26
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2020 filings • 501(c)3 • $50M-$100M nonprofits